Pre-Operative Medication Guidelines
Sent on behalf of Dr. J Huang - July 25, 2024
Pre-Operative Medication Guidelines
Antiplatelet Medications: ASA, clopidogrel, ticagrelor, prasugrel
Antiplatelet Agent
|
When to STOP before surgery
|
ASA
|
No Need to Stop
|
Clopidogrel (Plavix)
Ticagrelor (Brilinta)
|
Hold for 6 full days, LAST DOSE 7 days before surgery
|
Prasugrel (Effient)
|
Hold for 7 full days, LAST DOSE 8 days before surgery
|
Parenteral Anticoagulants: low molecular weight heparin, unfractionated heparin, fondaparinux
Anticoagulant
|
When to STOP before surgery
|
VTE Prophylaxis Doses
|
Enoxaparin 40 mg sc qhs
Enoxaparin 30 mg sc qhs
|
LAST DOSE 1 day before surgery
|
Heparin 5000 units sc BID
|
LAST DOSE 1 day before surgery
|
Therapeutic anticoagulation
|
Enoxaparin 1.5 mg/kg sc daily
(preferred time is 1000h)
|
LAST DOSE 1000h 1 day before surgery
If the patient has been receiving doses at 2200h:
· Do NOT give a dose the evening before surgery
· Give last dose in the evening of 2 days before surgery OR convert patient to 1 mg/kg BID dosing and follow guideline for enoxaparin 1mg/kg sc BID
|
Enoxaparin 1 mg/kg sc BID
|
LAST DOSE 2 days before surgery
|
Fondaparinux
|
LAST DOSE at 1000h 2 days before surgery
|
|
|
Oral Anticoagulants: warfarin, dabigatran, apixaban, rivaroxaban, edoxaban
Oral Anticoagulant
|
When to STOP before surgery
|
Warfarin (Coumadin)
|
If NO bridging required (low thrombosis risk patients):
Hold warfarin for 5 full days, LAST DOSE 6 days before surgery
|
If bridging is required (high thrombosis risk patients):
1. Hold warfarin for 5 full days, LAST DOSE 6 days before surgery
2. Start enoxaparin 3 days before OR at a dose of 1.5 mg/kg sc daily in the morning (for patients with normal renal function)
3. LAST DOSE of enoxaparin to be given 1 day before surgery
Criteria for bridging may include: DVT less than 3 months ago, prosthetic mitral heart valves, high risk aortic valves (previous TIA/stroke, atrial fibrillation, severe LV dysfunction), cardiac thrombus presumed to be present less than 3 months
|
Direct Oral Anticoagulants (DOACs)
|
No overlapping is required between DOACs and LMWH
Start therapeutic LMWH or IV heparin only If DOAC is held for longer than the following stated days
|
Dabigatran (Pradaxa)
|
Determine patient’s renal function ( eGFR, mL/min/1.732)
Renal Function (eGFR, mL/min/1.732)
|
|
Hold dose
|
Equal or greater than 80 mL/min/1.732
|
|
3 days before surgery
|
50 - 70 mL/min/1.732
|
|
4 days before surgery
|
30 – 49 mL/min
|
|
5 days before surgery
|
In patients with severe renal dysfunction (CrCl less than 30 mL/min) who are generally ineligible for DOACs, peri-operative management is unclear.
|
Apixaban (Eliquis)
|
Determine patient’s renal function ( eGFR, mL/min/1.73m2)
Dose
|
Renal Function ( eGFR, mL/min/1.73m2)
|
|
Hold dose
|
5 mg BID
|
|
|
3 days before surgery
|
2.5 mg BID
|
Equal or greater than 30 mL/min/1.73m2
|
|
2 days before surgery
|
2.5 mg BID
|
Less than 30 mL/min/1.73m2
|
|
3 days before surgery
|
In patients with severe renal dysfunction (CrCl less than 30 mL/min) who are generally ineligible for DOACs, peri-operative management is unclear.
|
Rivaroxaban (Xarelto)
|
Dose
|
|
|
Hold dose
|
20 mg once daily
|
|
|
4 days before surgery
|
10 mg once daily
|
|
|
3 days before surgery
|
|
Edoxaban (Lixiana)
|
Determine patient’s renal function (eGFR, mL/min/1.73m2)
Dose
|
Renal Function ( eGFR, mL/min/1.73m2)
|
|
Hold dose
|
60 mg once daily
|
Equal or greater than 30 mL/min/1.73m2
|
|
4 days before surgery
|
60 mg once daily
|
Less than 30 mL/min/1.73m2
|
|
5 days before surgery
|
30 mg once daily
|
Equal or greater than 30 mL/min/1.73m2
|
|
2 days before surgery
|
30 mg once daily
|
Less than 30 mL/min/1.73m2
|
|
3 days before surgery
|
|
Anti-hypertensives: beta blockers, ACEis, ARBs, Entresto, CCBs, vasodilators, diuretics, MRAs, alpha agonists, alpha blockers, vasodilators, nitrates, direct rening inhibitors
Antihypertensive Agent
|
When to STOP before surgery
|
Beta blockers:
Atenolol, acebutolol, bisoprolol, carvedilol Metoprolol, nadolol, nebivolol, pindolol, propranolol, sotalol, timolol
|
CONTINUE on the morning of surgery (prevents POAF)
|
RAAS Inhibitors:
ACE-Inhibitors:
Ramipril, perindopril, fosinopril, lisinopril, quinapril, trandolapril, enalapril, cilazapril, benazepril, captopril
ARBs:
Candesartan, eprosartan, irbesartan, losartan, , olmesartan, telmisartan, valsartan
ARB/Neprilysin Inhibitor:
Sacubitril/valsartan (Entresto)
Direct Renin Inhibitor:
Aliskerin (Rasilez)
|
LAST DOSE day before surgery.
(Risk of vasoplegia post-op)
|
Diuretics:
Amiloride, chlorthalidone, furosemide, hydrochlorothiazide, indapamide, metolazone,
MRAs:
Eplerenone, spironolactone
|
HOLD on the morning of surgery
|
Alpha blocker:
Doxazosin, terazosin,
Alpha 2 agonists:
Clonidine, methyldopa
Calcium channel blockers:
Amlodipine, diltiazem, felodipine, nifedipine, verapamil
Nitrates:
Isosorbide dinitrate, nitroglycerin patch
Vasodilators:
Hydralazine
|
CONTINUE on the morning of surgery
|
Anti-hyperglycemic agents: Insulins, metformin, SGLT2is, GLP1s, DPP4is, sulfunylureas, acarbose, thiazolidinediones
· For outpatients: Refer to RADAR clinic if A1C >8.5% and surgery more than one week away
*Consensus with Endocrinology and Diabetes Educators
Antidiabetic Agent
|
When to STOP before surgery
|
Insulin
Long-acting e.g:
Glargine (Basaglar, Lantus, Toujeo)
Degludec (Tresiba)
Detemer (Levemer)
Intermediate-acting e.g:
Humulin N
Novolin ge NPH
Mixed insulin e.g:
Humalog Mix25
Humalog Mix40
Humulin 30/70
Novomix30
Short-acting e.g:
Aspart (Novorapid, Trurapi, Fiap)
Lispro (Humalog, Admelog)
Glulisine (Apidra)
Humulin R
Novolin ge Toronto
|
· Insulin pump: Consult Endocrinology
· Type I diabetes: Consult Endocrinology
· Long-acting basal or intermediate insulin: Give 75% of patient’s usual dose the night before AND on the morning of surgery
· Mixed insulins: HOLD on the morning of surgery
· Short-acting meal insulin: HOLD on the morning of surgery
|
SGLT2 inhibitors
canagliflozin (Invokana)
Dapagliflozin (Forxiga
Empagliflozin (Jardiance)
Canagliflozin/Metformin (Invokamet)
Empagliflozin/Metformin (synjardy)
Empagliflozin/Linagliptin (Giyxambi)
Dapagliflozin/Metformin (Xigduo)
Dapagliflozin/Saxagliptin (Qtern)
Ertugliflozin (Steglatto)
Ertugliflozin/Metformin (Segluromet)
Ertugliflozin/Sitagliptin (Steglujan)
|
(HOLD for 3 full days before and on morning of surgery. LAST DOSE 4 days before surgery - Risk of euglycemic DKA)
|
Metformin
Sulfonylureas:
Gliclazide (Diamicron), glyburide, glimepiride (Amaryl)
DPP4 inhibitors:
Linagliptin (Trajenta),
sitagliptin (Januvia), saxagliptin (Onglyza)
Thiazolidinediones;
Rosiglitazone,
pioglitazone (Actos)
Alpha-glucosidase Inhibitor: Acarbose
Meglitinides:
Repaglinide (Gluconorm), nateglinide (Starlix)
|
HOLD on the morning of surgery
(Consider holding longer in renal dysfunction or AKI)
|
GLP1 agonist:
Semaglutide (Ozempic, Rybelsus)
Dulaglutide (Trulicity)
Liraglutide (Viktoza, Saxenda)
Tirzepatide (Mounjaro)
Glargine/Lixisenatide (Soliqua®)
|
HOLD for ALL IN PATIENTS
(Risk of delayed gastric emptying and pulmonary aspiration during anesthesia)
· Weekly dosing: semaglutide sc (Ozempic), dulaglutide (Trulicity), Trizapatide (Mounjaro)
o If for weight loss: HOLD for 3 weeks preop if time allows
o If for diabetes: SKIP one dose preop
· Daily dosing: semaglutide po (Rybelsus), liraglutide (Viktoza or Saxenda), Soliqua
o HOLD for 2 days before surgery (last dose 3 days preop)
For Type 2 DM: If HbA1C > 8.5% and NOT taking insulin, refer to RADAR clinic preoperatively.
If no HbA1C available, please order one in PAC and refer to RADAR clinic as necessary.
|
Disease Modifying Agents DMARDs and Biologics:
**Consider risk of discontinuing therapy (disease flare-up) VS continuing therapy (increased risk of SSIs and wound healing) **
DMARD Agent
|
When to STOP before surgery
|
Leflunomide
|
HOLD 2 weeks before surgery and resume 1-2 weeks after surgery
|
Methotrexate
|
Consider holding 1 week before surgery and resume 1-2 weeks after surgery (e.g. in elderly and renal dysfunction when higher chance of build up occur)
|
Hydroxychloroquine
|
Continue with no interruption
|
Sulfasalazine
|
Continue with no interruption (consider holding 1 day before and resume 3 days after surgery)
|
Biologics Agent
|
When to STOP before surgery
(Generally, hold 2-3 half-lives) before surgery and restart in 2-4 weeks when good wound healing achieved with no evidence of infection
|
TNF-alpha inhibitors
|
· Adalimumab (q2 weeks injection): HOLD for 3 weeks
· Etanercept (weekly injection) : HOLD for 2 weeks; Last dose 3 weeks before surgery
· Golimumab (monthly injection): HOLD for 6 weeks (skip one injection)
· Infliximab (q 4-8 weeks injection) : HOLD for 8 weeks
· Certolizumab (monthly injection): HOLD for 6 weeks
· Tocilizumab
o SC injection: HOLD for 3 weeks
o IV injection: HOLD for 4 weeks
|
Rituximab
|
Plan surgery at the end of cycle
|
Abatcept
|
SC injection: HOLD 1 week
IV injection: HOLD 1 month
|
|
|